List of works - Emma Jones

A distinct chemokine axis does not account for enrichment of Foxp3(+) CD4(+) T cells in carcinogen-induced fibrosarcomas.

scientific article published on May 2015

Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors

scientific article published on 13 December 2010

CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue

scientific article published on 5 February 2015

CD25+ regulatory T cells and tumor immunity

scientific article

Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment

scientific article published in December 2001

Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice

scientific article published on 22 February 2002

Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens

article

Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors.

scientific article

Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation

scientific article

Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies

scientific article published on 01 October 2002

High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression.

scientific article

Home sweet home: the tumor microenvironment as a haven for regulatory T cells.

scientific article published on 16 July 2013

Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression

scientific article published on November 2003

Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology

scientific article published on 12 August 2013

Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV.

scientific article published on April 2014

Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered

article

Novel role of regulatory T cells in limiting early neutrophil responses in skin

scientific article published on 17 August 2010

Progression of carcinogen-induced fibrosarcomas is associated with the accumulation of naïve CD4+ T cells via blood vessels and lymphatics

scientific article

Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity.

scientific article published on 06 August 2012

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.

scientific article

Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancer

scientific article

T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion

scientific article published on 7 September 2012

The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen

scientific article published on 01 March 2005

The influence of CD25+ cells on the generation of immunity to tumour cell lines in mice

scientific article published on January 2004

The influence of macrophage inflammatory protein-1alpha on protective immunity mediated by antiviral cytotoxic T cells

The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment.

scientific article published on 11 May 2013

List of works by Emma Jones

A distinct chemokine axis does not account for enrichment of Foxp3(+) CD4(+) T cells in carcinogen-induced fibrosarcomas.

Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors

CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue

CD25+ regulatory T cells and tumor immunity

Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment

Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice

Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens

Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors.

Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation

Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies

High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression.

Home sweet home: the tumor microenvironment as a haven for regulatory T cells.

Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression

Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology

Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV.

Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered

Novel role of regulatory T cells in limiting early neutrophil responses in skin

Progression of carcinogen-induced fibrosarcomas is associated with the accumulation of naïve CD4+ T cells via blood vessels and lymphatics

Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity.

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.

Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancer

T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion

The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen

The influence of CD25+ cells on the generation of immunity to tumour cell lines in mice

The influence of macrophage inflammatory protein-1alpha on protective immunity mediated by antiviral cytotoxic T cells

The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment.